Hepatitis C test and treatment in one visit
Part of Digestive system, Infections clinical trials.
This study tests whether people who come to the emergency department can get tested for hepatitis C and start treatment right away, all in one visit. It aims to make treatment easier and faster for those who test positive.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 22 and 65 years old.
- You are visiting the emergency department and will have a hepatitis C antibody test as part of routine screening.
- You are well enough to go home after your emergency visit (not admitted to the hospital).
- You do not have advanced liver scarring (cirrhosis), liver cancer, or severe chronic kidney disease.
- You are not pregnant and do not have allergies to the study medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study offers a once-daily pill (Epclusa) to treat hepatitis C for people in jail who have never taken HCV medicine before. The goal is to see if starting treatment while incarcerated and continuing after release can cure the infection.
This study tests hepatitis C virus (HCV) treatment using medications called sofosbuvir and velpatasvir, with the goal of curing the infection. If you've been treated before and the virus came back, you may be eligible for retreatment with additional medication.
This study tests a team-based approach — a pharmacist, doctor, and patient navigator working together — to help people living in permanent supportive housing get hepatitis C care. If you have hepatitis C and live in DESC housing, the study will check how well this team helps you through treatment over 2 years.
This study compares two ways to treat hepatitis C: getting treatment at a local clinic near you, or the usual care at a central hospital. It aims to see if treatment at local clinics is safe, effective, and more convenient for patients.
This study looks at what patients think about and are willing to use a quick “point-of-care” blood test for hepatitis C virus (HCV) after a positive antibody screen. It may help the ER find people with possible active infection faster and improve how testing is offered.
This trial looks at hepatitis C treatment for people whose last antiviral medicines did not fully clear the virus. It may help by testing a study drug approach for people in Pakistan who still have active hepatitis C infection.
Hear when a new HEPATITIS C (HCV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.